Ceapro Inc. (CVE:CZO – Get Free Report)’s stock price fell 11.8% on Thursday . The company traded as low as C$0.23 and last traded at C$0.23. 5,850 shares changed hands during trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The stock’s fifty day simple moving average is C$0.22 and its two-hundred day simple moving average is C$0.23. The company has a market cap of C$17.62 million, a price-to-earnings ratio of -3.75 and a beta of 1.38. The company has a debt-to-equity ratio of 8.07, a quick ratio of 18.88 and a current ratio of 8.54.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Read More
- Five stocks we like better than Ceapro
- 3 Stocks to Consider Buying in October
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Stock Analyst Ratings and Canadian Analyst Ratings
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Best Stocks Under $5.00
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
